e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
Pulmonary circulation: clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Three dimensional (3D) analysis of septal curvature from cardiac magnetic resonance images to determine pulmonary hypertension severity
M. Gomberg-Maitland, F. Maffessanti, A. Patel, R. Lang, V. Mor-Avi (Chicago, United States Of America)
Source:
Annual Congress 2010 - Pulmonary circulation: clinical aspects
Session:
Pulmonary circulation: clinical aspects
Session type:
E-Communication Session
Number:
5602
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gomberg-Maitland, F. Maffessanti, A. Patel, R. Lang, V. Mor-Avi (Chicago, United States Of America). Three dimensional (3D) analysis of septal curvature from cardiac magnetic resonance images to determine pulmonary hypertension severity. Eur Respir J 2010; 36: Suppl. 54, 5602
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure
Source: Eur Respir J 2002; 20: 1519-1524
Year: 2002
A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
Clinical evaluation of RV wall stress in pulmonary arterial hypertension: A follow-up study using magnetic resonance imaging
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Late gadolinium enhancement (LGE), a marker of myocardial damage, can be detected by contrast enhanced-cardiac magnetic resonance imaging within the right ventricle of patients with severe pulmonary hypertension. The extent of LGE relates to RV performanc
Source: Eur Respir J 2004; 24: Suppl. 48, 235s
Year: 2004
Comparing cardiac magnetic resonance imaging in group 1 and group 4 pulmonary hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Three-dimensional reconstruction of the right ventricle from two-dimensional echocardiographic images: Validation of volume measurements against MRI
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension
Source: Eur Respir J 2009; 33: 1454-1466
Year: 2009
Magnetic resonance in pulmonary arterial hypertension: a noninvasive alternative in the assessment of right ventricular function
Source: Eur Respir J 2002; 20: Suppl. 38, 4s
Year: 2002
Effects of treatment for pulmonary hypertension on pulmonary artery distensibility determined by cardiac magnetic resonance imaging
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
The value of tools to assess pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 222-235
Year: 2011
Cardiac magnetic resonance imaging versus echocardiography for assessment of cardiac involvement in pulmonary sarcoidosis
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Right ventricular interaction in pulmonary arterial hypertension
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008
Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018
Regional measures of 3D lung mechanics using magnetic resonance imaging
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020
Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema
Source: Eur Respir J 2002; 19: 225-231
Year: 2002
Cardiac magnetic resonance imaging in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 526-534
Year: 2013
Tricuspid deceleration time predicts right atrial pressure in patients with suspected pulmonary hypertension: Preliminary experience with cardiac magnetic resonance imaging
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Repeatability and Sensitivity to change of right ventricular analysis methods using cardiac magnetic resonance imaging in PAH: results from the RESPIRE Study
Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept